Goldman Sachs lowers Pepsico stock price target on growth outlook

PepsiCo’s fiscal Q3 2026 adjusted EPS of $2.34 and revenue of $25.27 billion topped analyst estimates of $2.30 and $24.97 billion, respectively, but the company lowered its near-term outlook. Management narrowed fiscal 2026 organic sales growth guidance to approximately 3% and cut constant-currency EPS growth guidance to 1%–2%; volumes rose 0.5%, down from 1% in the prior quarter. Goldman Sachs lowered its price target to $165 from $180 while maintaining a Buy rating; shares were at $128.34, down 7.9% year to date.

Analysis

The headline is unrelated to the body, so treat this as a PepsiCo update and verify the underlying filing before acting. The key market question is whether pricing and cost reductions can stabilize earnings without further volume erosion. If price/mix is doing the work while units weaken, promotional intensity could rise and offset savings; broad price increases risk trading consumers down, while targeted channel actions may protect mix but add execution complexity. Re-franchising could improve capital intensity, but may also shift reported growth and economics—track organic growth, segment margins, and cash conversion rather than headline sales alone.

PEP’s valuation discount to KO is not automatically a mean-reversion opportunity: the weaker near-term profit outlook may justify some of it. Conversely, a large discount could offer asymmetric upside if volumes recover and margins stop deteriorating. KO is the cleaner defensive comparator, while CELH and MNST’s product launches are longer-dated and do not establish near-term demand acceleration; weak convenience/fuel traffic is a possible category headwind, not proof of weakness across all PepsiCo channels.

Near term, the revision to profit expectations matters more than a modest earnings beat or a broker price target. Over 1–3 months, watch channel-level pricing, promotional intensity, input costs, and next-quarter volume/margin trends. Over 6–18 months, the thesis depends on restructuring and portfolio actions translating into durable margin and cash-flow improvement. Falsifiers for a recovery thesis are continued volume declines, further guidance cuts, or margin deterioration despite cost actions.

Key Decisions for Investors

• Do not trade the gold-related headline; verify the article source and use PepsiCo’s filing and guidance as the primary evidence.
• Keep PEP on a catalyst watch rather than buying solely on the valuation discount or Goldman Sachs target. Reassess after evidence that volumes stabilize and margins improve; continued declines or another outlook reduction falsify the recovery case.
• For a relative-value expression, consider a small, risk-controlled long PEP/short KO only after PEP’s volume and margin trends turn; the spread can widen further if earnings quality continues to lag. Avoid an unconditional mean-reversion position.
• Track PEP segment-level organic volume, price/mix, margins, promotional spending, input-cost trends, and cash conversion; distinguish refranchising-related changes in reported results from underlying demand.
• Treat CELH and MNST product announcements as watch items, not a near-term trade signal. Revisit only with evidence of retail distribution, sell-through, and category demand, particularly in convenience and fuel channels.